HRT FINANCIAL LP

Position in FLGT — Fulgent Genetics, Inc.

CIK 1475597 NEW YORK, NY

Position in FLGT

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$738,523

-$2,524,815 QoQ

Shares Held

46,448

-62.6% QoQ

Ownership

0.164%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $56,167,229 across 14 Diagnostics & Research names. FLGT ranks #9 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DHR	Danaher Corp /De/	177,683	$33,688,696
2	MYGN	Myriad Genetics Inc	1,786,319	$8,038,435
3	MEDP	Medpace Holdings, Inc.	7,571	$3,635,518
4	QGEN	Qiagen N.V.	72,302	$2,894,972
5	SHC	Sotera Health Co	139,192	$1,996,013
6	ADPT	Adaptive Biotechnologies Corp	131,241	$1,821,625
7	PSNL	Personalis, Inc.	208,891	$1,330,635
8	VCYT	Veracyte, Inc.	31,312	$1,008,559

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$738,523	46,448	-62.6%	Shares	Defined	2026-05-14
2025-12-31	$3,263,338	124,223	+16.9%	Shares	Defined	2026-02-12
2025-09-30	$2,402,018	106,284	+6.8%	Shares	Defined	2025-11-14
2025-06-30	$1,977,821	99,488	-42.0%	Shares	Defined	2025-08-14
2025-03-31	$2,901,324	171,676	+306.7%	Shares	Defined	2025-05-15
2024-12-31	$779,563	42,207	+48.5%	Shares	Defined	2025-02-14
2024-09-30	$617,523	28,418	+404.8%	Shares	Defined	2024-11-12
2023-06-30	$208,478	5,630	-84.1%	Shares	Defined	2023-08-11
2023-03-31	$1,106,343	35,437	+24.0%	Shares	Defined	2023-05-12
2022-12-31	$850,814	28,570	—	Shares	Defined	2023-02-10
No filing history on record for this holder in this stock.